| Autor: |
Barbara Loteta, Annalisa Pitino, Martina Pitea, Caterina Alati, Giovanni Tripepi, Maria Caterina Mico', Maria Pellicano', Francesca Cogliandro, Gaetana Porto, Giorgia Policastro, Giovanna Utano, Ilaria Maria Delfino, Annalisa Sgarlata, Anna Scopelliti, Aurora Idato, Giovanni Laenza, Maria Altomonte, Graziella D'Arrigo, Mercedes Gori, Massimo Martino |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Frontiers in Hematology, Vol 3 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2813-3935 |
| DOI: |
10.3389/frhem.2024.1441070 |
| Popis: |
ObjectivesTo evaluate the efficacy of biosimilar (BIO) pegfilgrastim (PEG) in lymphoma patients after autologous stem cell transplantation (ASCT).Methods86 consecutive lymphoma patients who received BIO/PEG after ASCT were assessed. The primary endpoints of this study were the incidence of febrile neutropenia (FN) and time to neutrophil engraftment.ResultsMost patients were males (67.4%) with a median age of 48 years. FN occurred in 66 patients (76.7%), and most of the fever was grade 1-2. The median time to neutrophil engraftment was 9 days. The incidence of FN differs based on lymphoma type (p-value |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
